跳转至内容
Merck
所有图片(1)

Key Documents

G003763

HPLC Analysis of Cortocisteroids in Urine on Discovery® HS F5 after SPE using Discovery® DSC-CN

application for SPE, application for HPLC

登录查看公司和协议定价


About This Item

技術

HPLC: suitable
solid phase extraction (SPE): suitable

測試參數

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: human urine spiked with corticosteroids at 0.5 and 1.0 μg/mL and diluted in DI water (1:1, v/v)
SPE well plate: Discovery DSC-CN 96-well SPE, 100 mg/well (575636-U)
condition: 1 mL methanol; 1 mL DI water.
sample addition: 1 mL spiked urine
washing: 1 mL 20% methanol
elution: 1 mL methanol
eluate post-treatment: Evaporate eluate with nitrogen at 30 °C. Reconstitute in 200 μL mobile phase.
column: Discovery HS F5, 5 cm x 4.6 mm I.D., 3 μm particles (567504-U)
mobile phase: [A] methanol; [B] DI water; (40:60, A:B)
flow rate: 1.5 mL/min
column temp.: 35 °C
detector: UV, 240 nm
injection: 5 μL

適合性

application for HPLC
application for SPE

應用

clinical

法律資訊

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门